Tribulin in post-traumatic stress disorder

Psychological Medicine

Volumn 18, Issue 4, 1988, Pages 833-836

  Davidson, J ^a,b   Glover, Vivette ^a,b   Clow, Angela ^a,b   Kudler, H ^a,b   Meador, K ^a,b   Sandler, M ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRIBULIN;

ADULT; AGITATION; AROUSAL; CLINICAL ARTICLE; EXTRAVERSION; HUMAN; POSTTRAUMATIC STRESS DISORDER;

AROUSAL; COMBAT DISORDERS; FEMALE; HUMAN; MALE; MIDDLE AGE; MONOAMINE OXIDASE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0024234738     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291700009764     Document Type: Article

References (18)

1. Armando, I., Barontini, M., Levin, G., Simsolo, R., Glover, V. & Sandler, M. (1984). Exercise increases endogenous urinary monoamine oxidase - benzodiazepine receptor ligand inhibitory activity in normal children. Journal of the Autonomic Nervous System 11, 95–100.
2. Armando, I., Glover, V. & Sandler, M. (1986). Distribution of endogenous benzodiazepine receptor ligand monoamine oxidase inhibitory activity (tribulin) in tissues. Life Sciences 38, 2063–2067.
3. Bhattacharya, S. K., Glover, V., Sandler, M., Clow, A., Topham, A., Bernadt, M. & Murray, E. (1982). Raised endogenous monoamine oxidase inhibitor output in post-withdrawal alcoholics: effects of L-dopa and ethanol. Biological Psychiatry 17, 829–836.
4. Buchsbaum, M. S., Coursey, R. D. & Murphy, D. L. (1976). The biochemical high risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 194, 339–341.
5. Clow, A., Glover, V., Armando, I. & Sandler, M. (1983). New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor? Life Sciences 33 735–741.
6. Clow, A., Glover, V., Sandler, M. & Tiller, J. (1988a). Increased urinary tribulin output in generalised anxiety disorder. Psychopharmacology 95, 378–380.
7. Clow, A., Glover, V., Weg, M. W., Walker, P. L., Sheehan, D. V., Carr, D. B. & Sandler, M. (1988b). Urinary catecholamine metabolite and tribulin output during lactate infusion. British Journal of Psychiatry 152, 122–126.
8. Diagnostic and Statistical Manual of Mental Disorders 3rd ed. (1980). American Psychiatric Association: Washington, DC.
9. Elsworth, J. D. Dewar, D., Glover, V., Goodwin, B., Clow, A. & Sandler, M. (1986). Purification and characterization of tribulin, an endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor binding. Journal of Neural Transmission 67, 45–56.
10. Endicolt. J. & Spitzer, R. L. (1978). A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Archives of General Psychiatry 35, 837–844.
11. Eysenck, H. J. & Eynsenck, S. B. G. (1975). Manual of the Eysenck Personality Questionnaire (Junior and Adult). Hodder and Stoughton: London.
12. Glover, V., Bhattacharya, S. K., Sandler, M. & File, S. E. (1981). Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor. Nature 292, 347–349.
13. Glover. V., Reveley, M. A. & Sandler, M. (1980). Monoamine oxidase inhibitor in human urine. Biochemical Pharmacology 29, 467–470.
14. Hamilton, M. (1959), The assessment of anxiety states by rating. British Journal of Medical Psychiatry 32, 50–55.
15. Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6, 278–296.
16. Petursson, H., Reveley, M.A., Glover, V. & Sandler, M. (1981). Urinary MAO inhibitor in psychiatric illness. Psychiatry Research 2, 335–340.
17. Petursson, H., Bhattacharya, S. K., Glover, V., Sandler, M. & Lader, M. (1982). Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. British Journal of Psychiatry 140, 7–10.
18. Sandler, M. (1982). The emergence of tribulin. Trends in Pharmacological Science 3, 471–472.